HCCBP3MAG-58K MilliporeMILLIPLEX MAP Human Circulating Cancer Biomarker Magnetic Bead Panel 3 - Cancer Multiplex Assay
Circulating Cancer Biomarker Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple oncology biomarkers in various tumor types in human serum, plasma and cell culture samples.
More>> Circulating Cancer Biomarker Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous analysis of multiple oncology biomarkers in various tumor types in human serum, plasma and cell culture samples. Less<<Recommended Products
Áttekintés
Replacement Information |
---|
Kulcsspecifikációk táblázata
Analytes Available | Species Reactivity | Key Applications | Detection Methods |
---|---|---|---|
Cathepsin D Galectin-3 Ferritin Fibroblast Activation Protein IGFBP-3 Melanoma Inhibitory Activation Protein Myeloperoxidase Sex Hormone Binding Globulin | H | Mplex | Luminex xMAP |
References |
---|
Product Information | |
---|---|
Detection method | Luminex xMAP |
Configuration | Design your multiplex kit by choosing available analytes within this panel. |
Precision, % |
|
Panel Type | MAGNETIC Circulating Cancer |
Quality Level | MQ200 |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Recommended storage for kit components is 2 - 8°C. |
Packaging Information | |
---|---|
Material Size | 96-well plate |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Katalógusszám | GTIN |
HCCBP3MAG-58K | 04053252988448 |
Documentation
Protocols
Title |
---|
Protocol- HCCBP3MAG-58K |
MILLIPLEX MAP Human Circulating Cancer Biomarker Magnetic Bead Panel 3 - Cancer Multiplex Assay MSDS
Title |
---|
Brochure
Title |
---|
The Power of Biomarker Analysis |
Technical Info
Newsletters / Publications
Title |
---|
Article: Detection and localization of surgically resectable cancers with a multi-analyte blood test |